Apr 29, 2026
998:983
For every 983 shares held, investors received 998. The price per share adjusted from $82.70 to $81.46.
The split itself did not change the total investment value.
Steminent Biotherapeutics, Inc. (TPEX:7729) operates in the Biotechnology industry.
Steminent Biotherapeutics, Inc. company overviewSteminent Biotherapeutics, Inc.'s most recent stock split was on April 29, 2026. It was a 998-for-983 forward split, so shareholders received 998 shares for every 983 they held.
Steminent Biotherapeutics, Inc. (TPEX:7729) has split its stock 2 times: a 343-for-320 split on August 28, 2025 and a 998-for-983 split on April 29, 2026.
Steminent Biotherapeutics, Inc. has split its stock 2 times. This history records 2 forward splits between August 28, 2025 and April 29, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Steminent Biotherapeutics, Inc.'s 998-for-983 split on April 29, 2026, every 983 shares became 998 shares.
Steminent Biotherapeutics, Inc. has not announced a new split in our records. Its most recent split was on April 29, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:7729 split will appear on this page.
Already premium?